RA/FTP has two exclusive contracts with generic naloxone manufacturers who sell naloxone to us at an extremely discounted price. We purchase the naloxone directly from the companies with our Medical Director’s authority and store it securely at our warehouse.
Yes. Remedy Alliance/For the People purchases naloxone from manufacturers with the required credentials and takes possession of the product.
21 USC 353(e)(4)(C) contains exemptions for wholesale distributors providing emergency medications, especially during a declared Public Health Emergency.
No. RA/FTP is a non-profit organization (501c3 pending) that is supported by grants, donations and self-sustaining revenue generated by the sale of naloxone to funded programs. All revenue generated by the sale of naloxone at our modest, tiered prices (over cost to us) is used to support the infrastructure of RA/FTP, cover shipping and handling, and to acquire a supply of naloxone for donation to under-resourced harm reduction programs.
Not yet. We are hoping to work directly with generic manufacturers of nasal naloxone in the future as those products become available, in order to offer an affordable nasal product to harm reduction programs.
The majority of our programs are providing syringe access and harm reduction services directly to people who use drugs. They also provide access to naloxone for people at high risk of overdose at treatment programs, jails and prisons, or through mail order services.
2019 was the first year that our programs ordered and distributed over 1 million doses of naloxone. In 2020, during the height of the COVID19 pandemic, that number increased to 1.3 million doses. In the first quarter of 2021 before the Pfizer naloxone shortage disrupted access in April, our programs had already ordered 250,000 doses of naloxone. From 2017 through the first quarter of 2021, our programs purchased 3,948,860 naloxone doses.
We sure can! Schedule a consultation with us (always free for harm reduction programs) and we can help you navigate the barriers you face.